Aveanna Healthcare Holdings (AVAH) EBITDA (2020 - 2026)

Aveanna Healthcare Holdings has reported EBITDA for 7 years, with the latest figure at $71.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 55.22% year-over-year to $71.0 million; the trailing twelve-month figure through Jan 2026 stood at $256.5 million (up 83.47% YoY), and the FY2026 full-year result was $266.3 million, up 78.24% from the prior year.
• EBITDA for Q1 2026 stood at $71.0 million, up from $53.6 million in the prior quarter.
• The five-year high for EBITDA was $80.0 million in Q2 2025, with the low at -$456.4 million in Q3 2022.
• Historically, EBITDA has averaged -$14.9 million across 5 years, with a median of $29.3 million in 2023.
• Annual changes were most pronounced in 2023 — EBITDA slumped 1694.99% — and 2024, when it jumped 144.56%.
• Aveanna Healthcare Holdings' EBITDA stood at -$204.5 million in 2022, then soared by 114.33% to $29.3 million in 2023, then surged by 56.25% to $45.8 million in 2024, then rose by 17.07% to $53.6 million in 2025, then soared by 32.59% to $71.0 million in 2026.
• The last three EBITDA figures came in at $71.0 million (Q1 2026), $53.6 million (Q3 2025), and $80.0 million (Q2 2025), per Business Quant data.